336 related articles for article (PubMed ID: 16772537)
21. Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation.
Oliveto AH; Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1991 Apr; 257(1):8-18. PubMed ID: 1850479
[TBL] [Abstract][Full Text] [Related]
22. An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity.
Morgan D; Cook CD; Smith MA; Picker MJ
Anesth Analg; 1999 Feb; 88(2):407-13. PubMed ID: 9972766
[TBL] [Abstract][Full Text] [Related]
23. Respiratory effects of opioid full and partial agonists in rhesus monkeys.
Liguori A; Morse WH; Bergman J
J Pharmacol Exp Ther; 1996 Apr; 277(1):462-72. PubMed ID: 8613955
[TBL] [Abstract][Full Text] [Related]
24. Social and environmental influences on opioid sensitivity in rats: importance of an opioid's relative efficacy at the mu-receptor.
Smith MA; Chisholm KA; Bryant PA; Greene JL; McClean JM; Stoops WW; Yancey DL
Psychopharmacology (Berl); 2005 Aug; 181(1):27-37. PubMed ID: 15778888
[TBL] [Abstract][Full Text] [Related]
25. Sex differences in opioid antinociception.
Bartok RE; Craft RM
J Pharmacol Exp Ther; 1997 Aug; 282(2):769-78. PubMed ID: 9262340
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor.
Morgan D; Cook CD; Picker MJ
J Pharmacol Exp Ther; 1999 May; 289(2):965-75. PubMed ID: 10215676
[TBL] [Abstract][Full Text] [Related]
27. Cross-tolerance and mu agonist efficacy in pigeons treated with LAAM or buprenorphine.
Galici R; McMahon LR; France CP
Pharmacol Biochem Behav; 2005 Jul; 81(3):626-34. PubMed ID: 15946731
[TBL] [Abstract][Full Text] [Related]
28. Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine.
Walker EA; Young AM
J Pharmacol Exp Ther; 2002 Jul; 302(1):101-10. PubMed ID: 12065706
[TBL] [Abstract][Full Text] [Related]
29. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
Mori T; Ito S; Kita T; Narita M; Suzuki T; Sawaguchi T
Eur J Pharmacol; 2006 Feb; 532(1-2):81-7. PubMed ID: 16464448
[TBL] [Abstract][Full Text] [Related]
30. Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: importance of the drug's relative intrinsic efficacy at the mu receptor.
Morgan D; Picker MJ
Behav Pharmacol; 1996 May; 7(3):261-284. PubMed ID: 11224419
[TBL] [Abstract][Full Text] [Related]
31. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
[TBL] [Abstract][Full Text] [Related]
32. Antinociceptive Interactions between the Imidazoline I2 Receptor Agonist 2-BFI and Opioids in Rats: Role of Efficacy at the μ-Opioid Receptor.
Siemian JN; Obeng S; Zhang Y; Zhang Y; Li JX
J Pharmacol Exp Ther; 2016 Jun; 357(3):509-19. PubMed ID: 27056847
[TBL] [Abstract][Full Text] [Related]
33. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
Jones HE; Bigelow GE; Preston KL
J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
[TBL] [Abstract][Full Text] [Related]
34. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
35. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.
Cook CD; Barrett AC; Roach EL; Bowman JR; Picker MJ
Psychopharmacology (Berl); 2000 Jul; 150(4):430-42. PubMed ID: 10958085
[TBL] [Abstract][Full Text] [Related]
36. Analgesic effects of morphine and loperamide in the rat formalin test: interactions with NMDA receptor antagonists.
Sevostianova N; Danysz W; Bespalov AY
Eur J Pharmacol; 2005 Nov; 525(1-3):83-90. PubMed ID: 16297905
[TBL] [Abstract][Full Text] [Related]
37. Buprenorphine-induced hyperalgesia in the rat.
Wala EP; Holtman JR
Eur J Pharmacol; 2011 Jan; 651(1-3):89-95. PubMed ID: 21114985
[TBL] [Abstract][Full Text] [Related]
38. Additive and subadditive antiallodynic interactions between μ-opioid agonists and N-methyl D-aspartate antagonists in male rhesus monkeys.
Cornelissen JC; Steele FF; Rice KC; Nicholson KL; Banks ML
Behav Pharmacol; 2018 Feb; 29(1):41-52. PubMed ID: 29239974
[TBL] [Abstract][Full Text] [Related]
39. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
[TBL] [Abstract][Full Text] [Related]
40. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
Walker EA; Makhay MM; House JD; Young AM
J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
